Navigation Links
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
Date:9/3/2008

ugust 13, 2008.

7. WebMD Medical Reference in Collaboration with the Cleveland Clinic. Heart Disease: Coronary Artery Disease. http://www.webmd.com/heart- disease/guide/heart-disease-coronary-artery-disease. Accessed August 13, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061120/DSLLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
2. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
3. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
4. TRITON-TIMI 38 Stent Analysis Favors Prasugrel
5. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
8. Hibernation-On-Demand Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
9. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
10. New Study: Pine Bark Significantly Reduces Menstrual Pain
11. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...GO, Dec. 1 TargeGen has announced ... from a multi-center, US-based clinical,trial of ...s been scheduled at,the 2008 American Society of ...e presentation are as follows:, Title: ...available, JAK2-Selective ...
(Date:12/1/2008)...rl with Hypophosphatasia Treated With ENB-0040 at ...nipeg , , MONTREAL, Dec. 1 ...y focused on developing novel therapeutics for ser...t infant patient in its clinical program for hypop...yme Replacement Therapy (ERT) with ENB-0040 for th...
(Date:12/1/2008)...H MEETING, Pa., Dec. 1 ...ced that dosing of subjects has begun in study MSI...e Phase 1b study of trodusquemine (MSI-1436) in ov... novel therapeutic for the treatment of type 2 dia...erally to regulate insulin and leptin pathways thr...
(Date:12/1/2008)..., Dec. 1 GeoVax Labs, In...iotechnology company developing,human vaccines fo... Virus) and,other infectious agents, announced to... Trials will take place in twelve sites across Nor...in collaboration with The National Institutes of,...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Key to longer life 28in flies 29 lies in just 14 brain cells 1696 1Key to longer life 28in flies 29 lies in just 14 brain cells 1696 2Smart insulin nanostructures pass feasibility test UT study reports 1692 1Smart insulin nanostructures pass feasibility test UT study reports 1692 2Penn Veterinary Medicine report new strategy to create genetically modified animals 474 1Penn Veterinary Medicine report new strategy to create genetically modified animals 474 2UCSD study reveals the regulatory mechanism of key enzyme 1684 1UCSD study reveals the regulatory mechanism of key enzyme 1684 2
...ESS WIRE)--Jun 8, 2007 - Archemix Corp., a,biotech...ng,aptamers, announced the successful completion o..., ARC1779. ARC1779 is designed to,selectively bloc...elets by inhibiting the binding of von Willebrand ...tivated vWF is scientifically,recognized as the fi...
...NESS WIRE)--Jun 8, 2007 - NuPathe Inc., a,privatel...ounced,positive results from an initial Phase I st...ute migraine being developed,by NuPathe., NP101 co...phoretic transdermal technology with sumatriptan, ...raine in the United,States. Sumatriptan is also th...
Other Medicine Technology:Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
(Date:12/1/2008)...s effective against plantar fasciitis, researchers...s) -- Italian researchers say they,ve developed a ...inful foot condition known as plantar fasciitis. ,...oid injections guided by ultrasound, the researche...s rate in tackling a condition that afflicts about...
(Date:12/1/2008)...and Cookie Johnson Public Service Announcement (PS... , ABBOTT PARK, Ill., Dec. 1 /PRNewswire-FirstC... AIDS Day, the Magic Johnson Foundation and Abb...es, their family and friends about HIV/AIDS and it...social networking tool allows Facebook users to st...
(Date:12/1/2008)...wire/ -- Blue Cross Blue Shield of Michigan,provi...membership information,today to Michigan Attorney...r,information about Michigan,s individual health ...h of Michigan,s individual health insurance market...M, the state,s last-resort,insurance carrier, in ...
(Date:12/1/2008)... The United States, fif... right hand on Saturday, November 29, as Dr. Warre...anged the bandages. , , "Wow, it looks like...is room at Jewish Hospital. "It,s awesome," said ... Hondusky, a New York resident, went on to say, "...
Breaking Medicine News(10 mins):Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 2Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 3Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 4Health News:Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day 5Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3Health News:Fifth U.S. Hand Transplant Patient Gets Look at New Hand 2
...kers who have a say in how they quit are more like...ul. The study, which is based on psychologists E...ation, was conducted by a team of researchers led ...s at the University of Rochester. The crux of Sel...
...archers at Mayo Clinic College of Medicine in Roch...ir patients stop smoking by referring them to tob...randomly assigned eight general dental practitione...g regarding smoking cessation, or brief counseling...
...lysed in a Bihar district as hundreds of doctors w...ce in rescuing two abducted school students who a...tors in Begusarai district, about 125 km from the ...rike Thursday to protest the failure of the police...
...S) could help identify the places most at risk of ...ntify high-hazard 'locked zones' that can spawn gi...pulco, Mexico, held by the American Geophysical So...physical associations, claimed that GPS has been u...
Other Medicine News:Health News:Smokers Who Have a Say in How They Quit More Likely to Kick the Habit 2
... aspherical optics. Includes XHL halogen bulb. The...y means of the aspherical optical system avoids co...Beta 200 allows you to view the whole of the illum...il. Conventional ophthalmoscopes often let you see...
The Panoptic ophthalmoscope incorporates an innovative and patented new optical design called axial Pointsource optics. This enabling technology makes it easier to enter small pupils and provides a d
Woodlyn Refractor offers the option to either rotate the better-one better-two refinement knob, or rotate the low sphere disc.
The Ultramatic Rx Master is designed and constructed to provide years of reliable service and give the professional distinctive features that measurably improve procedures. It embodies the characteri
Medicine Products: